Jenscare Scientific Co. Ltd. Class H (HK:9877) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Jenscare Scientific Co. Ltd. has released encouraging six-month follow-up results from their TRAVEL II clinical trial, showing 97% device success and marked improvements in patients with severe tricuspid regurgitation. This includes significant enhancements in cardiac function and quality of life, with a promising safety profile for the LuX-Valve Plus, a transvascular tricuspid valve replacement system.
For further insights into HK:9877 stock, check out TipRanks’ Stock Analysis page.